Tapewire

Nasdaq · USD

CORT

CORCEPT THERAPEUTICS INC

Export transactions ↓
Tapewire entity
2620
SEC CIK
0001088856
Parsed reports
567

Last 12 months

Inside the activity.

2 purchase rows · 107 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202505
Jan 202601
Feb 202601
Mar 202623
Apr 202601
May 202605
Jun 2026012
Jul 2026026
Aug 2026018
Sep 2026015
Oct 202609

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 6, 2024 02:19 UTC
Lyon Joseph DouglasChief Accounting Officer
Tax withholdingCommon Stock 474 $24.06 $11,404.44
Disclosure

SEC source: 0000950170-24-026782 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,300

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F2 · balance_after: Includes 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:14 UTC
Maduck SeanSee Remarks
GrantCommon Stock 636 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026779 · ownership.xml · nonDerivative · entry 3

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,222

F5 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F2 · balance_after: Includes 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:14 UTC
Maduck SeanSee Remarks
GrantCommon Stock 636 $24.06 $15,302.16
Disclosure

SEC source: 0000950170-24-026779 · ownership.xml · nonDerivative · entry 2

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,586

F3 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024.

F4 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F2 · balance_after: Includes 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:14 UTC
Maduck SeanSee Remarks
Tax withholdingCommon Stock 505 $24.06 $12,150.30
Disclosure

SEC source: 0000950170-24-026779 · ownership.xml · nonDerivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,950

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F2 · balance_after: Includes 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:09 UTC
Guyer WilliamChief Development Officer
Tax withholdingCommon Stock 604 $24.06 $14,532.24
Disclosure

SEC source: 0000950170-24-026773 · ownership.xml · nonDerivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,039

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F2 · balance_after: Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:03 UTC
Mokari AtabakChief Financial Officer
GrantCommon Stock 554 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026760 · ownership.xml · nonDerivative · entry 3

Mokari Atabak · CIK 0001678419 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,536

F5 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F2 · balance_after: Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:03 UTC
Mokari AtabakChief Financial Officer
GrantCommon Stock 554 $24.06 $13,329.24
Disclosure

SEC source: 0000950170-24-026760 · ownership.xml · nonDerivative · entry 2

Mokari Atabak · CIK 0001678419 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,982

F3 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024.

F4 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F2 · balance_after: Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:03 UTC
Mokari AtabakChief Financial Officer
Tax withholdingCommon Stock 517 $24.06 $12,439.02
Disclosure

SEC source: 0000950170-24-026760 · ownership.xml · nonDerivative · entry 1

Mokari Atabak · CIK 0001678419 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,428

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F2 · balance_after: Includes 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 508 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Robb Gary CharlesChief Business Officer
GrantCommon Stock 697 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026707 · ownership.xml · nonDerivative · entry 3

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,203

F5 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F2 · balance_after: Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Robb Gary CharlesChief Business Officer
GrantCommon Stock 697 $24.06 $16,769.82
Disclosure

SEC source: 0000950170-24-026707 · ownership.xml · nonDerivative · entry 2

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,506

F3 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024.

F4 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F2 · balance_after: Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Robb Gary CharlesChief Business Officer
Tax withholdingCommon Stock 656 $24.06 $15,783.36
Disclosure

SEC source: 0000950170-24-026707 · ownership.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,809

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F2 · balance_after: Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:02 UTC Exercise / conversionStock option (right to buy) · Derivative 2,200 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0000950170-24-026758 · ownership.xml · derivative · entry 3

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 2,200 shares

Expires 2026-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:02 UTC SaleCommon Stock 2,200 $23.59 $51,898.00
Disclosure

SEC source: 0000950170-24-026758 · ownership.xml · nonDerivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:02 UTC Exercise / conversionCommon Stock 2,200 $5.86 $12,892.00
Disclosure

SEC source: 0000950170-24-026758 · ownership.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 14,842 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · derivative · entry 10

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,158

Underlying: Common Stock · 14,842 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 12,226 $0.00 Strike: $3.29 $0.00
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · derivative · entry 9

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,226 shares

Expires 2025-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
SaleCommon Stock 27,068 $25.97 $702,904.53
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · nonDerivative · entry 5

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,455

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionCommon Stock 14,842 $3.88 $57,586.96
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · nonDerivative · entry 4

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionCommon Stock 12,226 $3.29 $40,223.54
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · nonDerivative · entry 3

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 02:11 UTC
Lyon Joseph DouglasChief Accounting Officer
Exercise / conversionStock option (right to buy) · Derivative 1,000 $0.00 Strike: $11.35 $0.00
Disclosure

SEC source: 0000950170-24-018325 · ownership.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,167

Underlying: Common Stock · 1,000 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 02:11 UTC
Lyon Joseph DouglasChief Accounting Officer
SaleCommon Stock 1,000 $26.00 $26,000.00
Disclosure

SEC source: 0000950170-24-018325 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,774

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 02:11 UTC
Lyon Joseph DouglasChief Accounting Officer
Exercise / conversionCommon Stock 1,000 $11.35 $11,350.00
Disclosure

SEC source: 0000950170-24-018325 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionStock option (right to buy) · Derivative 4,760 $0.00 Strike: $3.29 $0.00
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · derivative · entry 8

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,226

Underlying: Common Stock · 4,760 shares

Expires 2025-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
SaleCommon Stock 4,760 $25.00 $119,000.00
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · nonDerivative · entry 2

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,455

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 01:06 UTC
Maduck SeanSee Remarks
Exercise / conversionCommon Stock 4,760 $3.29 $15,660.40
Disclosure

SEC source: 0000950170-24-017442 · ownership.xml · nonDerivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,215

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 582 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:47 UTC
Maduck SeanSee Remarks
GrantStock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014883 · ownership.xml · derivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:25 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
GrantStock option (right to buy) · Derivative 500,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014879 · ownership.xml · derivative · entry 1

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:20 UTC
Guyer WilliamChief Development Officer
GrantStock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014874 · ownership.xml · derivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:08 UTC
Lyon Joseph DouglasChief Accounting Officer
GrantStock option (right to buy) · Derivative 150,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014870 · ownership.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 00:59 UTC
Hunt HazelChief Scientific Officer
GrantStock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014863 · ownership.xml · derivative · entry 1

Hunt Hazel · CIK 0001698307 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 00:40 UTC
Mokari AtabakChief Financial Officer
GrantStock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014855 · ownership.xml · derivative · entry 1

Mokari Atabak · CIK 0001678419 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 00:38 UTC
Robb Gary CharlesChief Business Officer
GrantStock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.01 $0.00
Disclosure

SEC source: 0000950170-24-014853 · ownership.xml · derivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:39 UTC Exercise / conversionStock option (right to buy) · Derivative 2,200 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0000950170-24-010685 · ownership.xml · derivative · entry 3

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,150

Underlying: Common Stock · 2,200 shares

Expires 2026-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:39 UTC SaleCommon Stock 2,200 $22.00 $48,400.00
Disclosure

SEC source: 0000950170-24-010685 · ownership.xml · nonDerivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:39 UTC Exercise / conversionCommon Stock 2,200 $5.86 $12,892.00
Disclosure

SEC source: 0000950170-24-010685 · ownership.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2024 Filed Jan 13, 2024 01:06 UTC
Hunt HazelChief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0000950170-24-004343 · ownership.xml · derivative · entry 3

Hunt Hazel · CIK 0001698307 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2024-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
January 08, 2024 Filed Jan 13, 2024 01:06 UTC
Hunt HazelChief Scientific Officer
Tax withholdingCommon Stock 29,792 $27.46 $818,088.32
Disclosure

SEC source: 0000950170-24-004343 · ownership.xml · nonDerivative · entry 2

Hunt Hazel · CIK 0001698307 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,354

F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024.

Read SEC document
January 08, 2024 Filed Jan 13, 2024 01:06 UTC
Hunt HazelChief Scientific Officer
Exercise / conversionCommon Stock 50,000 $3.02 $151,000.00
Disclosure

SEC source: 0000950170-24-004343 · ownership.xml · nonDerivative · entry 1

Hunt Hazel · CIK 0001698307 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 00:14 UTC Exercise / conversionStock option (right to buy) · Derivative 2,200 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0000950170-24-002211 · ownership.xml · derivative · entry 3

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,350

Underlying: Common Stock · 2,200 shares

Expires 2026-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 00:14 UTC SaleCommon Stock 2,200 $22.11 $48,642.00
Disclosure

SEC source: 0000950170-24-002211 · ownership.xml · nonDerivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

Read SEC document
January 02, 2024 Filed Jan 5, 2024 00:14 UTC Exercise / conversionCommon Stock 2,200 $5.86 $12,892.00
Disclosure

SEC source: 0000950170-24-002211 · ownership.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2023 Filed Dec 23, 2023 00:29 UTC
Guyer WilliamChief Development Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $19.26 $0.00
Disclosure

SEC source: 0000950170-23-072771 · ownership.xml · derivative · entry 3

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 10,000 shares

Expires 2032-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 22, 2023 Filed Dec 23, 2023 00:29 UTC
Guyer WilliamChief Development Officer
SaleCommon Stock 10,000 $32.00 $320,000.00
Disclosure

SEC source: 0000950170-23-072771 · ownership.xml · nonDerivative · entry 2

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,643

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F1 · balance_after: Includes 1,472 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 22, 2023 Filed Dec 23, 2023 00:29 UTC
Guyer WilliamChief Development Officer
Exercise / conversionCommon Stock 10,000 $19.26 $192,600.00
Disclosure

SEC source: 0000950170-23-072771 · ownership.xml · nonDerivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,472 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 23:21 UTC
Robb Gary CharlesChief Business Officer
GiftCommon Stock 750 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-071652 · ownership.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,640

F1 · balance_after: Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 13, 2023 Filed Dec 16, 2023 02:31 UTC
Robb Gary CharlesChief Business Officer
OtherCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-070903 · ownership.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Custodial Account for Child

Disclosed balance after: 7,700

F1 · kind: These shares were transferred from the custodial account to the child's personal account.

F2 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Read SEC document
December 08, 2023 Filed Dec 13, 2023 01:46 UTC
Robb Gary CharlesChief Business Officer
GiftCommon Stock 639 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-069849 · ownership.xml · nonDerivative · entry 3

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Custodial Account for Child

Disclosed balance after: 8,700

F1 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Read SEC document
December 08, 2023 Filed Dec 13, 2023 01:46 UTC
Robb Gary CharlesChief Business Officer
GiftCommon Stock 639 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-069849 · ownership.xml · nonDerivative · entry 2

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Custodial Account for Child

Disclosed balance after: 8,700

F1 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Read SEC document
December 08, 2023 Filed Dec 13, 2023 01:46 UTC
Robb Gary CharlesChief Business Officer
GiftCommon Stock 639 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-069849 · ownership.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Custodial Account for Child

Disclosed balance after: 8,700

F1 · ownership.nature: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Read SEC document
December 06, 2023 Filed Dec 7, 2023 01:56 UTC
Robb Gary CharlesChief Business Officer
SaleCommon Stock 6,212 $27.01 $167,786.12
Disclosure

SEC source: 0000950170-23-068650 · ownership.xml · nonDerivative · entry 4

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,390

F1 · balance_after: Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.